Daslemia 50 mg Tablet
  1. Home
  2. Pharma Products
  3. Intas Pharmaceuticals Ltd
  4. Daslemia 50 mg Tablet

Daslemia 50 mg Tablet

Daslemia 50 mg Tablet contains dasatinib 50 mg and is an oral targeted anticancer medicine. It is mainly used to treat Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia. The tablet is a prescription medicine and should be taken under specialist medical supervision.

BUY NOW

Category

Dasatinib is a tyrosine kinase inhibitor that blocks BCR-ABL and other kinase proteins involved in the growth and survival of certain leukemia cells. This targeted action helps control the abnormal proliferation of cancerous blood cells. Regular monitoring of blood counts and clinical parameters is important because treatment may cause myelosuppression, fluid retention, bleeding, or other adverse effects. The dosage and treatment duration are individualized by the treating oncologist according to the leukemia type and treatment response.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 50 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 60 tablets
Manufacturer / Marketer Intas Pharmaceuticals Ltd

Product Also Known As

Daslemia 50mg Tablet, Daslemia 50 mg Tablet, Dasatinib 50mg Tablet, Dasatinib 50 mg Tablet, Dasatinib Oral Tablet, Dasatinib 50mg Anticancer Tablet, Dasatinib Leukemia Tablet